Market Tracker

09/01 1:05pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.88
Data as of Aug 29
 +0.08 / +1.18%
Today’s Change
5.40
Today|||52-Week Range
11.88
-6.90%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.80
Today’s open6.81
Day’s range6.76 - 6.92
Volume35,415
Average volume (3 months)65,563
Market cap$298.5M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...0.000.00%
SCMPSucampo Pharmaceutic...+0.13+1.92%
ECYTEndocyte Inc+0.38+5.44%
SVASinovac Biotech Ltd+0.03+0.55%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts